| Investigation of Gait, Foot Pressure Distribution and Balance in Parkinson's Patients With Motor Freezing (NCT05107531) | Hacettepe University | 2021-09-10 |
| Dopamine Effect on Inhibitory Control (NCT03665493) | Giovanni Mirabella | 2020-09-30 |
| The Acute Effect of Cervical Mobilization in Parkinson's Disease (NCT04524143) | Hacettepe University | 2020-09-02 |
| The Acute Effect of Lumbosacral Mobilization in Parkinson's Disease (NCT04524182) | Hacettepe University | 2020-09-01 |
| Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease (NCT03065192) | Neurocrine Biosciences | 2017-05-11 |
| PET/MR Imaging in Patients With Short and Long Standing Parkinson's Disease (NCT02801110) | david groshar | 2016-06-01 |
| Sleep, Awake & Move - Part II (NCT02710487) | Neurocenter of Southern Switzerland | 2016-03-03 |
| Online Cognitive Training in PD, MS and Depressed Patients Treated With Electroconvulsive Therapy (NCT02525367) | Amsterdam UMC, location VUmc | 2016-03-01 |
| Exploring Mechanisms for Neuropsychiatric Symptoms of Parkinson Disease Using Transcranial Direct Current Stimulation (NCT03074812) | Johns Hopkins University | 2016-02-01 |
| Volumetric Bone Mineral Density and it's Relationship With Osteoporotic Fractures in Parkinson's Disease (NCT03095690) | Centre Hospitalier Régional d'Orléans | 2016-01-07 |
| Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease (NCT02610231) | Kyowa Kirin Co., Ltd. | 2015-12-01 |
| PA Behavior and HRQoL in Parkinson's Disease Patients Patients: Role of Social Cognitive Variables (NCT05575479) | Ohio State University | 2015-08-01 |
| Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients (NCT02453386) | Biotie Therapies Inc. | 2015-07-01 |
| Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes (NCT02242487) | Acorda Therapeutics | 2015-03-01 |
| Randomized Safety Study of CVT-301 Compared to an Observational Control Group (NCT02352363) | Acorda Therapeutics | 2015-03-01 |
| Infusion of Apomorphine: Long-term Safety Study (NCT02339064) | MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals | 2015-02-01 |
| Whole-body Vibration as a Treatment for Parkinson's Disease (NCT02306863) | Sun Life Financial Movement Disorders Research and Rehabilitation Centre | 2015-01-01 |
| Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes (NCT02240030) | Acorda Therapeutics | 2014-11-01 |
| Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease (NCT02227355) | UCB Biopharma S.P.R.L. | 2014-09-01 |
| Vascular Abnormalities in Idiopathic Parkinson's Disease (NCT02045420) | University of Saskatchewan | 2013-12-01 |
| A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease (NCT01968031) | Kyowa Kirin Co., Ltd. | 2013-10-01 |
| Foot Mechanical Stimulation for Treatment of Gait and Gait Related Disorders in Parkinson's Disease and Progressive Supranuclear Palsy. (NCT01815281) | IRCCS San Raffaele Roma | 2013-07-01 |
| Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes (NCT01777555) | Acorda Therapeutics | 2013-04-01 |
| Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease (NCT01789047) | Rush University Medical Center | 2013-03-01 |
| Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy (NCT01782222) | UCB BIOSCIENCES GmbH | 2013-02-01 |
| Efficacy of Acupuncture and Bee Venom Acupuncture on Patients With Idiopathic Parkinson's Disease (NCT01970813) | Kyunghee University Medical Center | 2012-10-01 |
| Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients (NCT01646268) | UCB Pharma | 2012-07-01 |
| Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients (NCT01646255) | UCB Pharma | 2012-07-01 |
| Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease (NCT01606670) | UCB Pharma GmbH | 2012-05-01 |
| Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes (NCT01617135) | Acorda Therapeutics | 2012-05-01 |
| Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients (NCT01523301) | UCB Korea Co., Ltd. | 2012-04-01 |
| Robot Walking Rehabilitation in Parkinson's Disease (NCT01668407) | IRCCS San Raffaele Roma | 2012-03-30 |
| The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease (NCT01470859) | Huashan Hospital | 2011-12-01 |
| Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support (NCT01330290) | UCB Pharma | 2011-03-01 |
| Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor Symptoms (NCT01300819) | UCB Pharma | 2011-02-01 |
| Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037) (NCT01227265) | Merck Sharp & Dohme LLC | 2010-11-19 |
| Vercise Implantable Stimulator for Treating Parkinson's Disease (NCT01221948) | Boston Scientific Corporation | 2010-10-01 |
| Change in Gastrointestinal Complaints After Switch From Oral Parkinson's Disease Treatment to Neupro® Transdermal Patch (NCT01159691) | UCB Pharma GmbH | 2010-06-01 |
| Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists (NCT01007864) | Desitin Arzneimittel GmbH | 2010-01-01 |
| Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease (NCT00985517) | Sangamo Therapeutics | 2009-10-29 |
| MOTION, Safinamide in Early Idiopathic Parkinson's Disease (IPD), as add-on to Dopamine Agonist (Extension of Trial 27918) (NCT01028586) | Newron Pharmaceuticals SPA | 2009-10-01 |
| A Study to Assess the Effect of Safinamide on Levodopa Pharmacokinetics (NCT01026428) | Newron Pharmaceuticals SPA | 2009-09-01 |
| Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa (NCT00627640) | Newron Pharmaceuticals SPA | 2009-02-01 |
| Efficacy of Transdermal Nicotine, on Motor Symptoms in Advanced Parkinson's Disease (NCT00873392) | Assistance Publique - Hôpitaux de Paris | 2009-02-01 |
| Impact of Deep Brain Stimulation of Subthalamic Nucleus on the Hepatic Glucose Production in Parkinson's Disease (NCT00663312) | University Hospital, Clermont-Ferrand | 2008-04-01 |
| MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist (NCT00605683) | Newron Pharmaceuticals SPA | 2007-11-01 |
| Facial Expression Recognition of Emotion and Categorization of Emotional Words in Parkinson's Disease. Impact of L-Dopa and Deep Brain Stimulation of Subthalamic Nucleus (NCT00664157) | University Hospital, Clermont-Ferrand | 2007-09-01 |
| The APOS System: Effects on Gait, Mobility and QOL in Patients With Parkinson's Disease (NCT00498758) | Tel-Aviv Sourasky Medical Center | 2007-08-01 |
| The Effectiveness of Biofeedback Treatment in Constipated Patients With Idiopathic Parkinson's Disease (NCT00869830) | Asan Medical Center | 2007-01-01 |
| Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 in Subjects With Idiopathic Parkinson's Disease (NCT00400634) | Sangamo Therapeutics | 2006-11-01 |
| Comparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's Disease (NCT00279825) | Impax Laboratories, LLC | 2006-01-01 |
| Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease (NCT00239564) | Impax Laboratories, LLC | 2005-10-01 |
| Stalevo in Early Wearing-Off Patients (NCT00125567) | Orion Corporation, Orion Pharma | 2005-08-01 |
| A Multi-Center, Observational Safety Registry of Subjects With Idiopathic Parkinson's Disease Previously Treated With Intraputaminal Infusion of Liatermin (NCT00148369) | Amgen | 2005-06-01 |
| Walking Capacity in Parkinson's Disease (PD-Walk) (NCT00261781) | Natalie Allen | 2005-05-01 |
| An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease (NCT00505687) | UCB Pharma | 2005-02-01 |
| Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (NCT00643045) | Newron Pharmaceuticals SPA | 2004-12-01 |
| A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's Disease (NCT00243945) | UCB Pharma | 2004-12-01 |
| Study of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease (NCT00115427) | Amgen | 2003-03-01 |